Bruton's tyrosine kinase inhibitors for multiple sclerosis




Airas, Laura

PublisherElsevier BV

2025

Lancet Neurology

The Lancet Neurology

24

8

627

628

1474-4422

DOIhttps://doi.org/10.1016/S1474-4422(25)00238-8

https://doi.org/10.1016/s1474-4422(25)00238-8




I have obtained consulting fees from Novartis, Sanofi, and Merck Serono and compensation for lectures from Sanofi and Merck Serono.


Last updated on 2025-04-09 at 13:44